三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益
AK104-302研究显示卡度尼利单抗联合化疗在胃癌全人群获益
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:961KB
图片尺寸:2303*1080
同报告图片
/
4
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
fCDliIbmnJ8gfCDmlbDph48gfAp8IC0tLSB8IC0tLSB8CnwgSUlJ5pyfIHwgOTIgfAp8IEkvSUnmnJ8gfCA4NiB8CnwgSUnmnJ8gfCAyOTYgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yM5Y2O56aP6K+B5Yi456CU56m25omA77yI5oiq6IezMjAyNOW5tDbmnIgyNeaXpe+8iQ==
所属报告:
康方生物-港股公司研究报告-肺癌大适应症先发优势占位IO 2.0的未来已来-240708(31页).pdf
打包全文图表
相关数据
ZG005和AK104在宫颈癌的数据对比(截至20250720)
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
收藏
行业数据
2025-08-01
原图定位
查看详情
AK104宫颈癌1L治疗注册临床安全性数据
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC877yM6KGo5qC85LiL5pa55bGV56S65LqG6LWE5paZ5p2l5rqQ44CCCgp8IOS4jeiJr+S6i+S7tuexu+WeiyB8IOivlemqjOe7hOWPkeeUn+eOhyB8IOWvueeFp+e7hOWPkeeUn+eOhyB8CnwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCDiiaUz57qn5rK755aX55u45YWz5LiN6Imv5LqL5Lu2IChURUFFKSB8IDg1LjQwJSAgICAgICB8IDgwLjQwJSAgICAgICB8Cnwg5Lil6YeN5LiN6Imv5LqL5Lu2IChTQUUpICAgICAgICAgfCA1NS44MCUgICAgICAgfCAzMy44MCUgICAgICAgfAp8IOayu+eWl+S4reaWreeOhyAoRGlzY29udGludWF0aW9uKSB8IDI3LjkwJSAgICAgICB8IDEwLjUwJSAgICAgICB8Cnwg4omlM+e6p+WFjeeWq+ebuOWFs+S4jeiJr+S6i+S7tiAoaXJBRSkgfCA5LjcwJSAgICAgICAgfCAwLjkwJSAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaTGFuY2V077yM5Lic5ZC06K+B5Yi456CU56m25omA
收藏
行业数据
2025-07-08
原图定位
查看详情
K药、AK112、AK104适应症布局梳理(绿色为获批,蓝色为III期,黄色为II期)
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
收藏
行业数据
2025-07-08
原图定位
查看详情
AK104销售预测(单位均为亿人民币)
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
收藏
行业数据
2025-07-08
原图定位
查看详情
AK104与Volrustomig的安全性比较(NSCLC)
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
收藏
行业数据
2025-07-08
原图定位
查看详情
AK104同靶点研发竞争格局(截至2025年5月31日)
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
收藏
竞争格局
2025-07-08
原图定位
查看详情
2022H2-2023H2卡度尼利单抗销售额(亿元)
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
收藏
行业数据
2024-10-21
原图定位
查看详情
卡度尼利单抗在全人群优于贝伐和化疗
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗与纳武利尤单抗联合伊匹木单抗相比安全性更优
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
收藏
其它
2024-07-10
原图定位
查看详情
开坦尼®(卡度尼利,PD-1/CTLA-4)临床研究计划
fCDkuqflk4HvvIjpnbbngrnvvIkgfCDluIPlsYDpoobln58gfCDljZXoja8v6IGU5ZCI55aX5rOVIHwg6YCC5bqU55eHIHwgSWHmnJ8gfCBJYi9JSeacnyB8IOWFs+mUri9JSUnmnJ8gfCBOREEvQkxB6YCS5LqkL+iOt+aJuSB8CnwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwKfCDljaHluqblsLzliKnvvIhQRC0xL0NUTEEtNO+8iSB8IOWuq+miiOeZjCB8IOWNleiNryB8IDIxLzNM5a6r6aKI55mMIHwgIHwgIHwgIHwgMjAyMi42LjI56I635om5IHwKfCDljaHluqblsLzliKnvvIhQRC0xL0NUTEEtNO+8iSB8IOWuq+miiOeZjCB8ICvljJbnlpcv6LSd5LyQ54+g5Y2V5oqXIHwgMUzlrqvpoojnmYwgfCAgfCAgfCAgfCAgfAp8IOWNoeW6puWwvOWIqe+8iFBELTEvQ1RMQS0077yJIHwg6IOD55mMIHwg5Y2V6I2vIHwg5paw6L6F5Yqp5rK755aX5a6r6aKI55mMIHwgIHwgIHwgIHwgIHwKfCDljaHluqblsLzliKnvvIhQRC0xL0NUTEEtNO+8iSB8IOiDg+eZjCB8ICtYRUxPWOWMlueWl+aWueahiCB8IDFM6IOD55mML+iDg+mjn+euoee7k+WQiOmDqOiFuueZjCB8ICB8ICB8ICB8ICB8Cnwg5Y2h5bqm5bC85Yip77yIUEQtMS9DVExBLTTvvIkgfCDog4PnmYwgfCArQUsxMDkr5YyW55aXIHwgUEQtKEwpMeayu+eWl+WQjui/m+WxleeahOiDgy/og4Ppo5/nrqHnu5PlkIjpg6johbrnmYwgfCAgfCAgfCDlt7LlkK/liqggfCAgfAp8IOWNoeW6puWwvOWIqe+8iFBELTEvQ1RMQS0077yJIHwg6IOD55mMIHwgK0FLMTE3K+WMlueWlyB8IDFM6IOD55mML+iDg+mjn+euoee7k+WQiOmDqOiFuueZjCB8ICB8ICB8ICB8ICB8Cnwg5Y2h5bqm5bC85Yip77yIUEQtMS9DVExBLTTvvIkgfCDog4PnmYwgfCArQUsxMTcr5YyW55aXIHwg5paw6L6F5Yqp5rK755aX6IODL+iDg+mjn+euoee7k+WQiOmDqOiFuueZjCB8ICB8ICB8ICB8ICB8Cnwg5Y2h5bqm5bC85Yip77yIUEQtMS9DVExBLTTvvIkgfCDogp3nu4bog57nmYwgfCDljZXoja8gfCDogp3nu4bog57nmYzmnK/lkI7ovoXliqnmsrvnlpcgfCAgfCAgfCDlhaXnu4TkuK0gfCAgfAp8IOWNoeW6puWwvOWIqe+8iFBELTEvQ1RMQS0077yJIHwg6IKd57uG6IOe55mMIHwgK+S7keS8kOabv+WwvCtUQUNFIHwg5Lit5pyf6IKd57uG6IOe55mMIHwgIHwgIHwg5bey5ZCv5YqoIHwgIHwKfCDljaHluqblsLzliKnvvIhQRC0xL0NUTEEtNO+8iSB8IOiCnee7huiDnueZjCB8ICvku5HkvJDmm7/lsLwgfCAxTOiCnee7huiDnueZjCB8ICB8ICB8ICB8ICB8Cnwg5Y2h5bqm5bC85Yip77yIUEQtMS9DVExBLTTvvIkgfCDogp3nu4bog57nmYwgfCArQUsxMDkgfCBQRC0oTCkx5rK755aX5ZCO6L+b5bGV55qE6IKd57uG6IOe55mMIHwgIHwgIHwgIHwgIHwKfCDljaHluqblsLzliKnvvIhQRC0xL0NUTEEtNO+8iSB8IOiCnee7huiDnueZjCB8ICtBSzExMiB8IDFM6IKd57uG6IOe55mMIHwgIHwgIHwgIHwgIHwKfCDljaHluqblsLzliKnvvIhQRC0xL0NUTEEtNO+8iSB8IOiCnee7huiDnueZjCB8ICvljJbnlpcgfCAxTCBQRC1MMeihqOi+vumYtOaAp+mdnuWwj+e7huiDnuiCuueZjCB8ICB8ICB8IOWFpee7hOS4rSB8ICB8Cnwg5Y2h5bqm5bC85Yip77yIUEQtMS9DVExBLTTvvIkgfCDogp3nu4bog57nmYwgfCAr6KW/5aWl572X5bC8IHwg4omlMkzlsI/nu4bog57ogrrnmYwgfCAgfCAgfCAgfCAgfAp8IOWNoeW6puWwvOWIqe+8iFBELTEvQ1RMQS0077yJIHwg6IK655mMIHwgK+ilv+Wlpee9l+WwvCB8IOWQiOWMlueWl+WSjFBELShMKTHmsrvnlpfov5vlsZXnmoTpnZ7lsI/nu4bog57ogrrnmYwgfCAgfCAgfCAgfCAgfAp8IOWNoeW6puWwvOWIqe+8iFBELTEvQ1RMQS0077yJIHwg6IK655mMIHwgK0FLMTA5K+ilv+Wlpee9l+WwvCB8IFBELShMKTHmsrvnlpflkI7ov5vlsZXnmoTpnZ7lsI/nu4bog57ogrrnmYwgfCAgfCAgfCAgfCAgfAp8IOWNoeW6puWwvOWIqe+8iFBELTEvQ1RMQS0077yJIHwg6IK655mMIHwgK0FLMTEywrHljJbnlpcgfCDmmZrmnJ/pnZ7lsI/nu4bog57ogrrnmYwgfCAgfCAgfCAgfCAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45a6Y572R77yM5Y2O56aP6K+B5Yi456CU56m25omA
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗肝癌销售峰值有望超20亿元
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
收藏
其它
2024-07-10
原图定位
查看详情
卡度尼利单抗胃癌销售峰值有望超20亿元
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
收藏
其它
2024-07-10
原图定位
查看详情
AK104治疗一线宫颈癌对比联合疗法适用患者增加PD-L1CPS<1部分,III期研究已达PFS终点
fCDoja/lk4HlkI3np7AgfCBBSzEwNCB8IOW4leWNmuWIqeePoOWNleaKlyvotJ3kvJDnj6DljZXmipcgfAp8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg5LyB5LiaIHwg5bq35pa555Sf54mpIHwgTVNEL+e9l+awjyB8Cnwg5pyA6auY6Zi25q61IHwgSUlJ5pyfIHwg5LiK5biCIHwKfCDmjIfljZfmjqjojZAgfCAvIHwgTkNDTjIwMjQgcHJlZmVycmVk5o6o6I2Q77yIUEQtTDHpmLPmgKfvvIk8YnI+Q1NDTzIwMjMgSUnnuqfmjqjojZDvvIhQRC1MMemYs+aAp++8iSB8Cnwg5bey6K+75Ye65pWw5o2u5Li05bqK6K+V6aqMIHwgQUsxMDQtMzAzIHwgQ09NUEFTU0lPTi0xMzxicj5LRVlOT1RFLTgyNiB8Cnwg6K+V6aqM6K6+6K6hJuWfuue6vyB8IEFLMTA06IGU5ZCI5ZCr6ZOC5YyW55aXKy8t6LSd5LyQ54+g5Y2V5oqX5a+55q+U5a6J5oWw5YmC6IGU5ZCI5ZCr6ZOC5YyW55aXKy8t6LSd5LyQ54+g5Y2V5oqX55So5LqO5LiA57q/5rK755aX5oyB57ut5aSN5Y+R5oiW6L2s56e75oCn5a6r6aKI55mM77yMUEQtTDEgQ1BTIDwgMeeahOaCo+iAheWNoOavlOe6pjI2JSB8IOS4gOe6v+Wuq+miiOeZjO+8jOWFtuS4rVBELUwxIENQUyA8IDEvMS08MTAv4omlMTDljaDmr5TvvJpBSzEwNCAxNW1nL2tnIFEzdyArIOWMlueWl++8iDMzLjMlLzMzLjMlLzMzLjMl77yJIC8gQUsxMDQgMTBtZy9rZyBRM3cgKyDljJbnlpfvvIg1MCUvMjUlLzI1Je+8iSAvIEFLMTA0IDEwbWcva2cgUTN3ICsg5YyW55aXK+i0neS8kOePoOWNleaKl++8iDI4LjYlLzQyLjklLzI4LjYl77yJPGJyPumavuayu+WkjeWPkei9rOenu+Wuq+miiOeZjO+8jHBlbWJybytjaGVtbyB2cyBwbGFjZWJvK2NoZW1v77yMK+i0neS8kOePoO+8iOWMu+eUn+WGs+Wumu+8ie+8jFBELUwxIENQUyA8IDHnmoTmgqPogIXljaDmr5QxMS40JSB2cyAxMSUgfAp8IOS+i+aVsO+8iOWNleiHgi/lrp7pqoznu4QgdnMg5a+554Wn57uE77yJIHwg6K6h5YiS5YWl57uENDQw5Lq6IHwgMTUgdnMgMTYgdnMgMTQ8YnI+5rK755aXMzA4IHZzIDMwOSB8Cnwg5pyJ5pWI5oCn5pWw5o2u77yI5Y2V6IeCL+WunumqjOe7hCB2cyDlr7nnhafnu4TvvIkgfCDkuI7lronmhbDliYLogZTlkIjpk4LljJbnlpcrLy3otJ3kvJDnj6DljZXmipfnm7jmr5TvvIzljaHluqblsLzliKnogZTlkIjlkKvpk4LljJbnlpcrLy3otJ3kvJDnj6DljZXmipflnKhQRlPmnInnu5/orqHlrabmmL7okZfmlLnlloTvvIjlhajkurrnvqTvvIzljbPml6DorrpQRC1MMeihqOi+vu+8jOWMheWQq1BELUwxIENQU+KJpTHkurrnvqTku6Xlj4pQRC1MMSBDUFMgPCAx5Lq6576k77yJIHwgSVRUOjxicj5PUlI9NjYuNyUvNjguOCUvOTIuMyU8YnI+5LiJ5Liq6Zif5YiX77yaPGJyPlBELUwxIENQUyA8IDEvMS08MTAv4omlMTA6PGJyPk9SUj02Ni43JS84Ni43JS83MC42JTxicj5QRC1MMSBDUFMg4omlIDE6PGJyPk9SUj02OC4xJSB2cyA1MC4yJTxicj5tUEZTPTEwLjQgdnMgOC4ybTxicj4yeSBPc3JhdGU9NTMlIHZzIDQxLjclPGJyPm1QRlM9MTAuNCB2cyA4LjJtPGJyPjJ5IE9zcmF0ZT01MC40JSB2cyA0MC40JSB8Cnwg5a6J5YWo5oCn5pWw5o2u77yI5Y2V6IeCL+WunumqjOe7hCB2cyDlr7nnhafnu4TvvIkgfCDlronlhajmgKfnibnlvoHkuI7ml6LlvoDmiqXpgZPnmoTnm7jlhbPkuLTluornoJTnqbbnu5PmnpzkuIDoh7TvvIzml6DmlrDnmoTlronlhajmgKfkv6Hlj7cgfCDiiaUzIFRSQUVzPTYwJS83NSUvODUuNyU8YnI+4omlMyBBRXM9ODEuOCUgdnMgNzUuMSUgfAoK6LWE5paZ5p2l5rqQ77yaUHViTWVk77yMTkVKTe+8jOS4reazsOivgeWIuOeglOeptuaJgA==
收藏
其它
2024-06-25
原图定位
查看详情
AK104治疗末线宫颈癌对比其他国内外指南优先推荐疗法在全人群展现较好的疗效风险比
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
收藏
其它
2024-06-25
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
既往研究已表明,患者 PD-L1 低表达/阴性接受免疫治疗的疗效普遍不佳。AK104-302研究中,PD-L1 CPS<5(PD-L1低表达)和 PD-L1 CPS<1(PD-L1阴性)人群占比分别达 49.8%和 23%,期中分析结果显示,中位随访时间达 18.7个月,卡度尼利联合治疗组和对照组接受后续系统治疗的比例分别为 36.4% vs 50.5%,后续治疗使用 PD-1/L1 抑制剂的分别占 11.1% vs 21.6%。无论 PD-L1 表达,mOS 为 15个月,12个月 OS率为 57.3%,全人群死亡风险降低 38%(HR=0.62);PD-L1 CPS≥5时,mOS为达到,死亡风险降低 44%(HR=0.56)。
其它
原图定位
当前图表所属:
康方生物-港股公司研究报告-肺癌大适应症先发优势占位IO 2.0的未来已来-240708(31页).pdf
PD-1/PD-L1抑制剂开发联合化疗、靶向疗法以及其他免疫疗法
默沙东在ADC领域的交易汇总
K药正在进行中的全球临床管线(按疾病)
K药正在进行中的全球临床管线(按分期)
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》